PTN · Palatin Technologies Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '24 | Q2 '24 | Q3 '24 | Q2 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.92M | $116.0K | $0 | - | $0 | $869.7K | $2.03M | $0 | $1.03M | $1.20M |
| Cost of Revenue | - | - | - | - | - | $0 | $97.6K | $0 | - | - |
| Gross Profit | - | - | - | - | - | $869.7K | $1.94M | $0 | - | - |
| R&D | $3.52M | $4.32M | $2.53M | $3.43M | $3.76M | $5.74M | $5.55M | $7.16M | $4.37M | $4.83M |
| SG&A | $1.98M | $3.12M | $1.66M | $1.68M | $1.47M | $2.02M | $3.03M | $2.03M | $3.32M | $3.54M |
| Total Operating Expenses | $5.50M | $7.44M | $4.19M | $2.61M | $4.81M | $7.76M | $861.0K | $9.22M | $6.61M | $8.50M |
| D&A | $53.3K | $14.4K | $14.4K | - | - | $80.8K | - | - | - | - |
| Operating Income | ($1.58M) | ($7.33M) | $4.66M | ($2.61M) | ($4.81M) | ($7.76M) | $1.17M | ($9.22M) | ($5.59M) | ($7.30M) |
| Interest Expense | $1.8K | $3.8K | $2.0K | $3.8K | $1.8K | $5.9K | $1.6K | $1.3K | $5.5K | $3.4K |
| Income Tax | - | - | - | - | - | - | $0 | $0 | ($4.67M) | $0 |
| Net Income | ($1.43M) | ($7.26M) | $4.68M | ($2.44M) | ($4.81M) | ($7.82M) | ($7.84M) | ($8.44M) | ($1.42M) | ($7.15M) |
| EPS - Basic | ($9.13) | ($2.86) | $4.81 | ($28.00) | - | ($21.50) | - | - | - | - |
| EPS - Diluted | ($0.37) | ($5.92) | ($19.71) | - | ($26.50) | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '24 | Q2 '24 | Q3 '24 | Q2 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.16M | $14.48M | $1.27M | $2.56M | $2.52M | $2.38M | $9.53M | $21.49M | $10.98M | $19.63M |
| Accounts Receivable | - | $1.64M | $0 | - | - | $1.35M | $0 | $0 | $2.92M | $1.70M |
| Inventory | - | - | - | - | - | $1.60M | $0 | $0 | $526.0K | $630.0K |
| Accounts Payable | $1.69M | $5.45M | $7.41M | $7.00M | $7.77M | $3.95M | $4.10M | $3.44M | $4.30M | $2.79M |
| Current Assets | $12.79M | $17.47M | $8.37M | $2.92M | $3.23M | $2.61M | $9.77M | $10.27M | $16.32M | $24.24M |
| Total Assets | $13.23M | $17.93M | $8.61M | $3.27M | $3.73M | $3.42M | $10.74M | $11.41M | $17.94M | $25.61M |
| Current Liabilities | $2.54M | $6.33M | $8.22M | $8.01M | $10.05M | $9.86M | $9.66M | $8.53M | $15.13M | $11.85M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.63M | $6.46M | $8.22M | $8.04M | $10.12M | $11.10M | $10.85M | $9.83M | $17.81M | $16.02M |
| Stockholders' Equity | $10.59M | $11.47M | $396.4K | ($4.78M) | ($6.39M) | ($7.69M) | ($111.5K) | $1.58M | $134.1K | $9.59M |
| Retained Earnings | ($463.09M) | ($461.66M) | ($454.40M) | ($459.07M) | ($456.84M) | ($449.59M) | ($441.77M) | ($433.52M) | ($415.54M) | ($404.82M) |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '24 | Q2 '24 | Q3 '24 | Q2 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($1.62M) | - | - | ($7.02M) | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | $0 | - | - | - | - |
| Financing Cash Flow | - | - | $328.2K | - | - | ($127.0K) | - | - | - | - |
| CapEx | - | - | - | - | - | $0 | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | ($7.02M) | - | - | - | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '24 | Q2 '24 | Q3 '24 | Q2 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | 100.0% | 95.2% | - | - | - |
| Operating margin | -40.3% | -6315.8% | - | - | - | -892.8% | 57.7% | - | -544.3% | -610.6% |
| EBITDA margin | -39.0% | -6303.4% | - | - | - | -883.6% | - | - | - | - |
| Net margin | -36.5% | -6260.0% | - | - | - | -899.6% | -385.6% | - | -138.7% | -597.8% |
| Free cash flow margin | - | - | - | - | - | -806.8% | - | - | - | - |
| FCF / Net income | - | - | - | - | - | 0.90 | - | - | - | - |
| R&D / Revenue | 89.7% | 3722.8% | - | - | - | 660.5% | 273.1% | - | 425.5% | 404.0% |
| SG&A / Revenue | 50.6% | 2693.0% | - | - | - | 232.4% | 149.1% | - | 323.2% | 295.8% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -10.8% | -40.5% | 54.3% | -74.8% | -129.0% | -229.1% | -73.0% | -74.0% | -7.9% | -27.9% |
| Return on equity | -13.5% | -63.4% | 1180.0% | 51.1% | 75.3% | 101.8% | 7035.2% | -534.3% | -1062.2% | -74.5% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 5.04 | 2.76 | 1.02 | 0.36 | 0.32 | 0.26 | 1.01 | 1.20 | 1.08 | 2.05 |
| Quick ratio | 5.04 | 2.76 | 1.02 | 0.36 | 0.32 | 0.10 | 1.01 | 1.20 | 1.04 | 1.99 |
| Cash ratio | 4.01 | 2.29 | 0.15 | 0.32 | 0.25 | 0.24 | 0.99 | 2.52 | 0.73 | 1.66 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -880.8x | -1927.0x | 2328.2x | -686.6x | -2681.4x | -1307.2x | 730.9x | -7351.1x | -1018.2x | -2126.2x |
| Equity multiplier | 1.25 | 1.56 | 21.73 | -0.68 | -0.58 | -0.44 | -96.35 | 7.22 | 133.80 | 2.67 |
| Liabilities / Assets | 0.20 | 0.36 | 0.95 | 2.46 | 2.71 | 3.25 | 1.01 | 0.86 | 0.99 | 0.63 |
| Efficiency | ||||||||||
| Asset turnover | 0.30 | 0.01 | 0.00 | - | 0.00 | 0.25 | 0.19 | 0.00 | 0.06 | 0.05 |
| Inventory turnover | - | - | - | - | - | 0.00 | - | - | - | - |
| Days sales outstanding | - | 5147d | - | - | - | 566d | 0d | - | 1037d | 519d |
| Days inventory outstanding | - | - | - | - | - | - | 0d | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | 15334d | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | -15334d | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 6.4x | 3.4x | 21.9x | - | - | - | - | - | - | - |
| P / S | 17.4x | 336.6x | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | 1.6x | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | 98.2% | -100.0% | 310.6% | 453.3% |
| Revenue CAGR (3y) | 48.6% | -51.6% | - | - | - | - | - | - | 267.9% | - |
| Revenue CAGR (5y) | 113.3% | - | - | - | - | 90.7% | - | - | -37.3% | -33.2% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 67.2% | -180.6% | - | - | 47.8% | 11.3% | - | -26.3% | 33.9% | 6.6% |
| Net income growth (YoY) | 70.2% | -197.4% | - | 68.9% | 43.0% | 5.2% | -450.8% | -18.0% | 83.6% | 6.3% |
| EPS growth (YoY) | 98.6% | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | -4184.5% | - | - | - | -83.5% | -99.2% | -65.8% |
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing PALATIN TECHNOLOGIES INC against the 5 most active filers in the same SIC group.